Related Experiment Video
Updated: Dec 21, 2025

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay
Published on: May 5, 2016
Early Oral Antibiotic Switch for Staphylococcus aureus Bacteremia: Many Are Called, but Few Are Chosen
1Duke University Medical Center, Durham, North Carolina, USA thomas.holland@duke.edu.
Abstract:
Staphylococcus aureus bacteremia (SAB) is a complicated, high-risk disease. For selected low-risk SAB, the role of oral antibiotic stepdown therapy is unknown. Bupha-Intr et al. report a retrospective cohort of low-risk SAB patients who did well with a short duration of intravenous antibiotics, followed by an additional ∼10 days of oral antibiotics, primarily using beta-lactams. Prospective trials will help further define the efficacy of this approach.
More Related Videos
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Antibiotic Selection
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Dosage Regimen: Multiple Oral Dosage

